Increased P53 Immunopositivity in Anaplastic Medulloblastoma and Supratentorial PNET is Not Caused by JC Virus

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2005 Feb 19

PMID 15717928

Citations 19

Authors

Charles G Eberhart

Aneeka Chaudhry

Richard W Daniel

Leila Khaki

Keerti V Shah

Patti E Gravitt

Affiliations

Soon will be listed here.

Abstract

Background: p53 mutations are relatively uncommon in medulloblastoma, but abnormalities in this cell cycle pathway have been associated with anaplasia and worse clinical outcomes. We correlated p53 protein expression with pathological subtype and clinical outcome in 75 embryonal brain tumors. The presence of JC virus, which results in p53 protein accumulation, was also examined.

Methods: p53 protein levels were evaluated semi-quantitatively in 64 medulloblastomas, 3 atypical teratoid rhabdoid tumors (ATRT), and 8 supratentorial primitive neuroectodermal tumors (sPNET) using immunohistochemistry. JC viral sequences were analyzed in DNA extracted from 33 frozen medulloblastoma and PNET samples using quantitative polymerase chain reaction.

Results: p53 expression was detected in 18% of non-anaplastic medulloblastomas, 45% of anaplastic medulloblastomas, 67% of ATRT, and 88% of sPNET. The increased p53 immunoreactivity in anaplastic medulloblastoma, ATRT, and sPNET was statistically significant. Log rank analysis of clinical outcome revealed significantly shorter survival in patients with p53 immunopositive embryonal tumors. No JC virus was identified in the embryonal brain tumor samples, while an endogenous human retrovirus (ERV-3) was readily detected.

Conclusion: Immunoreactivity for p53 protein is more common in anaplastic medulloblastomas, ATRT and sPNET than in non-anaplastic tumors, and is associated with worse clinical outcomes. However, JC virus infection is not responsible for increased levels of p53 protein.

Citing Articles

The pivotal role of irradiation-induced apoptosis in the pathogenesis and therapy of medulloblastoma.

Richard S Cancer Rep (Hoboken). 2024; 7(4):e2048.

PMID: 38599791 PMC: 11006592. DOI: 10.1002/cnr2.2048.

Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway.

Naeem A, Harish V, Coste S, Parasido E, Choudhry M, Kromer L Mol Cancer Res. 2021; 20(1):114-126.

PMID: 34635507 PMC: 8738155. DOI: 10.1158/1541-7786.MCR-21-0277.

TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.

Maynard R, Poore B, Hanaford A, Pham K, James M, Alt J Cancer Lett. 2021; 504:137-145.

PMID: 33571541 PMC: 9195565. DOI: 10.1016/j.canlet.2021.02.001.

Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation.

Schultz L, Haltom J, Almeida M, Wierson W, Solin S, Weiss T Dis Model Mech. 2018; 11(6).

PMID: 29914980 PMC: 6031359. DOI: 10.1242/dmm.034124.

Endogenous Retrovirus 3 - History, Physiology, and Pathology.

Bustamante Rivera Y, Brutting C, Schmidt C, Volkmer I, Staege M Front Microbiol. 2018; 8:2691.

PMID: 29379485 PMC: 5775217. DOI: 10.3389/fmicb.2017.02691.

References

Weggen S, Bayer T, Deimling A, Reifenberger G, von Schweinitz D, Wiestler O . Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol. 2000; 10(1):85-92. PMC: 8098548. DOI: 10.1111/j.1750-3639.2000.tb00245.x. View

Miralbell R, Tolnay M, Bieri S, Probst A, Sappino A, Berchtold W . Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. J Neurooncol. 2000; 45(2):103-10. DOI: 10.1023/a:1006330324991. View

Marino S, Vooijs M, van der Gulden H, Jonkers J, Berns A . Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 2000; 14(8):994-1004. PMC: 316543. View

Biegel J, Fogelgren B, Zhou J, James C, Janss A, Allen J . Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res. 2000; 6(7):2759-63. View

Wetmore C, Eberhart D, Curran T . Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 2001; 61(2):513-6. View

Yuan C, Miley W, Waters D . A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods. 2001; 91(2):109-17. DOI: 10.1016/s0166-0934(00)00244-5. View

Hayashi H, Endo S, Suzuki S, Tanaka S, Sawa H, Ozaki Y . JC virus large T protein transforms rodent cells but is not involved in human medulloblastoma. Neuropathology. 2001; 21(2):129-37. DOI: 10.1046/j.1440-1789.2001.00384.x. View

Kinoshita Y, Shiratsuchi H, Tamiya S, Oshiro Y, Hachitanda Y, Oda Y . Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis. J Cancer Res Clin Oncol. 2001; 127(6):351-8. DOI: 10.1007/s004320000217. View

Woodburn R, Azzarelli B, Montebello J, Goss I . Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors. J Neurooncol. 2001; 52(1):57-62. DOI: 10.1023/a:1010691330670. View

10.

Pomeroy S, Tamayo P, Gaasenbeek M, Sturla L, Angelo M, McLaughlin M . Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002; 415(6870):436-42. DOI: 10.1038/415436a. View

11.

Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S . Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst. 2002; 94(4):267-73. DOI: 10.1093/jnci/94.4.267. View

12.

Eberhart C, Kepner J, Goldthwaite P, Kun L, Duffner P, Friedman H . Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer. 2002; 94(2):552-60. DOI: 10.1002/cncr.10189. View

13.

Giordana M, Duo D, Gasverde S, Trevisan E, Boghi A, Morra I . MDM2 overexpression is associated with short survival in adults with medulloblastoma. Neuro Oncol. 2002; 4(2):115-22. PMC: 1920659. DOI: 10.1093/neuonc/4.2.115. View

14.

Burns A, Jaros E, Cole M, Perry R, Pearson A, Lunec J . The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system. Br J Cancer. 2002; 86(7):1117-23. PMC: 2364191. DOI: 10.1038/sj.bjc.6600151. View

15.

Kim J, Koralnik I, LeFave M, Segal R, Pfister L, Pomeroy S . Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro Oncol. 2002; 4(3):165-70. PMC: 1920639. DOI: 10.1093/neuonc/4.3.165. View

16.

Kraus J, Felsberg J, Tonn J, Reifenberger G, Pietsch T . Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood. Neuropathol Appl Neurobiol. 2002; 28(4):325-33. DOI: 10.1046/j.1365-2990.2002.00413.x. View

17.

Sarkar C, Pramanik P, Karak A, Mukhopadhyay P, Sharma M, Singh V . Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol. 2002; 59(1):49-61. DOI: 10.1023/a:1016357731363. View

18.

Saylors 3rd R, Sidransky D, Friedman H, Bigner S, Bigner D, Vogelstein B . Infrequent p53 gene mutations in medulloblastomas. Cancer Res. 1991; 51(17):4721-3. View

19.

Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L . High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 1992; 7(6):1159-66. View

20.

Fanning E, Knippers R . Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem. 1992; 61:55-85. DOI: 10.1146/annurev.bi.61.070192.000415. View